Showing 34,802 results

Filters
New & experimental hepatitis C treatment

Merck’s four-week treatment for hepatitis C misses the mark

Editor's pick
Wall Street Journal
11 November 2014
Low & theoretical transmission risks

An HIV Transmission Case Possibly Associated with Manicure Care

Editor's pick
AIDS Research and Human Retroviruses
11 November 2014
Sexually transmitted infections prevention

Missed HPV vaccination opportunities: a consequence of avoiding awkward conversations

Editor's pick
BMJ
11 November 2014
Epidemiology & behaviour

More straight people than gay people being diagnosed with HIV in Kent

Editor's pick
Pink News
11 November 2014
Improving HIV care

South Africa: SA Can Overcome HIV Challenge - Deputy President

Editor's pick
AllAfrica.com
11 November 2014
Vaginal rings & topical PrEP

Misunderstanding of questions regarding anal sex in microbicide HIV prevention trial

News
10 November 2014
New & experimental HIV treatments

Once-daily dolutegravir superior to darunavir/ritonavir in 96-week follow-up

News
10 November 2014
New & experimental HIV treatments

Doravirine works as well as efavirenz with fewer CNS side-effects

News
10 November 2014
Harm reduction

Addiction services in England: in need of an intervention

Editor's pick
The Lancet Psychiatry
10 November 2014
New & experimental hepatitis C treatment

Phase 3 UNITY Trials Demonstrate High Cure Rates for Investigational, All-Oral Daclatasvir TRIO Fixed-Dose Combination in Genotype 1 Hepatitis C Patients, Including Those with Cirrhosis

Editor's pick
Bristol-Myers Squibb press release
10 November 2014
New & experimental hepatitis C treatment

ALLY Trial Demonstrates High Cure Rates for Investigational Daclatasvir and Sofosbuvir Combination among Genotype 3 Hepatitis C Patients

Editor's pick
Bristol-Myers Squibb press release
10 November 2014
New & experimental hepatitis C treatment

Achillion Reports 100% SVR12 in a Phase 2 Combination Study With ACH-3102 at the Liver Meeting 2014 (AASLD)

Editor's pick
Achillion press release
10 November 2014
HIV prevention policy

Time for the UK to get ready for PrEP

Editor's pick
The Lancet HIV
10 November 2014
New & experimental hepatitis C treatment

Merck's Four-Week Hepatitis C Regimen Fails to Top Gilead

Editor's pick
Bloomberg
10 November 2014
The search for a cure

Scientists see mechanism for spontaneous HIV 'cure'

Editor's pick
AFP / Yahoo News
10 November 2014
Pharmaceutical industry

HIV generics in the U.S.: Sooner or later?

Editor's pick
The Body
10 November 2014
New & experimental hepatitis C treatment

Sofosbuvir/ledipasvir cures nearly all genotype 1 HCV for people with HIV co-infection

News
10 November 2014
Hepatitis C treatment

Sustained virological response to hepatitis C treatment reduces mortality, liver cancer and liver transplants

News
10 November 2014
Combatting stigma

Panic, Paranoia, and Public Health — The AIDS Epidemic's Lessons for Ebola

Editor's pick
New England Journal of Medicine
8 November 2014
PrEP

Rupert Whitaker: A pill for risky sex—another step on the road to a pill for bad housing

Editor's pick
BMJ Group Blogs
8 November 2014
Changing treatment

Protease inhibitor monotherapy: darunavir/ritonavir less effective than three-drug therapy

News
7 November 2014
Young people

Learning, Dating and Hooking Up: Sex Education Goes Online in Cambodia

Editor's pick
Inter Press Service
7 November 2014
Retention & linkage to care

Study Finds Retention Problems Among South African Patients Receiving HIV Treatment

Editor's pick
Boston University press release
7 November 2014
New & experimental HIV treatments

Innovation in fixed-dose combos: HIV/AIDS therapeutics edition

Editor's pick
BioPharma Dive
7 November 2014